Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
nash
2
×
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
2025
ad-comm
affimed
akcea therapeutics
allergan
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
biotech
blueprint medicineas
boulder/denver blog main
boulder/denver top stories
briefing docs
bristol-myers squibb
car-t
celgene
cervical cancer
clinical data
clinical study
clinical trial
clinical trials
commissioner
What
new
2
×
allogene
approved
bio
cancer
crispr
data
disease
diversity
drug
fatty
horizon
hot
immunotherapy
intercept
investors
ipo
juno
known
liver
marketed
medicine
million
nash
nearly
nonalcoholic
remains
roundup
shares
snapped
steatohepatitis
therapeutics
ticket
track
utero
years
Language
Current search:
nash
×
new
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
